D. Raccah

6.1k total citations · 1 hit paper
113 papers, 4.1k citations indexed

About

D. Raccah is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, D. Raccah has authored 113 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Endocrinology, Diabetes and Metabolism, 34 papers in Surgery and 31 papers in Molecular Biology. Recurrent topics in D. Raccah's work include Diabetes Management and Research (54 papers), Diabetes Treatment and Management (42 papers) and Pancreatic function and diabetes (31 papers). D. Raccah is often cited by papers focused on Diabetes Management and Research (54 papers), Diabetes Treatment and Management (42 papers) and Pancreatic function and diabetes (31 papers). D. Raccah collaborates with scholars based in France, United States and United Kingdom. D. Raccah's co-authors include P Vague, B. Vialettes, Mireille Henry, Fabrice Armougom, Didier Raoult, T. Coste, P. Miossec, John E. Gerich, Roch Giorgi and B. Ridings and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Diabetes Care.

In The Last Decade

D. Raccah

110 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients

2009 671 citations B. Vialettes, D. Raccah et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Raccah France	33	2.0k	1.4k	1.0k	859	586	113	4.1k
Jaipaul Singh United Kingdom	38	1.3k 0.7×	1.8k 1.3×	783 0.8×	1.0k 1.2×	438 0.7×	208	5.1k
C Ionescu-Tîrgovişte Romania	24	1.6k 0.8×	604 0.4×	821 0.8×	1.1k 1.3×	1.2k 2.0×	147	4.3k
Vaia Lambadiari Greece	34	1.8k 0.9×	1.0k 0.7×	614 0.6×	906 1.1×	373 0.6×	181	4.6k
Yuzo Sato Japan	33	1.1k 0.5×	1.1k 0.8×	281 0.3×	1.3k 1.5×	183 0.3×	164	4.3k
George Dimitriadis Greece	40	2.1k 1.1×	1.4k 1.0×	1.1k 1.1×	1.3k 1.5×	497 0.8×	185	5.6k
Hong Chen China	27	952 0.5×	843 0.6×	344 0.3×	678 0.8×	222 0.4×	127	2.9k
Jeong‐a Kim United States	34	1.0k 0.5×	1.9k 1.4×	608 0.6×	1.5k 1.8×	225 0.4×	93	5.7k
Μelpomeni Peppa Greece	32	2.7k 1.4×	656 0.5×	444 0.4×	1.2k 1.4×	245 0.4×	101	5.4k
Matthias Möhlig Germany	42	1.9k 1.0×	1.9k 1.4×	859 0.9×	2.5k 2.9×	615 1.0×	111	7.6k
T. D. R. Hockaday United Kingdom	32	1.4k 0.7×	580 0.4×	547 0.5×	1.4k 1.7×	647 1.1×	130	3.9k

Countries citing papers authored by D. Raccah

Since Specialization

Citations

This map shows the geographic impact of D. Raccah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Raccah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Raccah more than expected).

Fields of papers citing papers by D. Raccah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Raccah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Raccah. The network helps show where D. Raccah may publish in the future.

Co-authorship network of co-authors of D. Raccah

This figure shows the co-authorship network connecting the top 25 collaborators of D. Raccah. A scholar is included among the top collaborators of D. Raccah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Raccah. D. Raccah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armand, Martine, et al.. (2020). Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices. Diabetes Technology & Therapeutics. 23(4). 259–267. 11 indexed citations

Raccah, D., Bruno Guerci, Mayank Ajmera, et al.. (2019). Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis. Endocrinology Diabetes & Metabolism. 2(3). e00061–e00061. 2 indexed citations

Raccah, D.. (2017). Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options. Diabetes & Metabolism. 43(2). 110–124. 14 indexed citations

Roussel, Ronan, et al.. (2016). Low rate of intensification in type 2 diabetic patients inadequately controlled with basal insulin: the INTERDIA study. Diabetes Management. 6(6). 119–127. 2 indexed citations

Raccah, D., Jay Lin, Edward Wang, et al.. (2013). Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials. Journal of Diabetes and its Complications. 28(1). 40–44. 27 indexed citations

Guerci, Bruno, Louis Monnier, Pierre Sérusclat, et al.. (2012). Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study. Diabetes & Metabolism. 38(4). 359–366. 70 indexed citations

Philippé, Jan & D. Raccah. (2009). Treating type 2 diabetes: how safe are current therapeutic agents?. International Journal of Clinical Practice. 63(2). 321–332. 68 indexed citations

Raccah, D., et al.. (2008). C‐Peptide Effects on Renal Physiology and Diabetes. Journal of Diabetes Research. 2008(1). 281536–281536. 15 indexed citations

Raccah, D.. (2008). Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 10(s2). 76–82. 31 indexed citations

10.

Raccah, D., et al.. (2007). At Low Doses, a γ-Linolenic Acid-Lipoic Acid Conjugate Is More Effective Than Docosahexaenoic Acid-Enriched Phospholipids in Preventing Neuropathy in Diabetic Rats. Journal of Nutrition. 137(2). 368–372. 15 indexed citations

11.

Conrath, J., et al.. (2006). Semi‐automated detection of the foveal avascular zone in fluorescein angiograms in diabetes mellitus. Clinical and Experimental Ophthalmology. 34(2). 119–123. 20 indexed citations

12.

Boubred, Farid, et al.. (2006). C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes & Metabolism. 32(3). 223–228. 34 indexed citations

13.

Conrath, J., Roch Giorgi, B. Ridings, & D. Raccah. (2005). Metabolic factors and the foveal avascular zone of the retina in diabetes mellitus. Diabetes & Metabolism. 31(5). 465–470. 13 indexed citations

14.

Conrath, J., Roch Giorgi, D. Raccah, & B. Ridings. (2004). Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye. 19(3). 322–326. 210 indexed citations

15.

Raccah, D., et al.. (2003). Differential Effect of w3 PUFA Supplementations on Na,K-ATPase and Mg-ATPase Activities: Possible Role of the Membrane w6/w3 Ratio. The Journal of Membrane Biology. 191(1). 37–47. 24 indexed citations

16.

Gallice, Philippe, T. Coste, Martin Jannot, et al.. (2000). The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism. 49(7). 868–872. 32 indexed citations

17.

Raccah, D., et al.. (1996). Decreased Na/K ATPase Ouabain Binding Sites in Red Blood Cells of Patients with Insulin-Dependent Diabetes and Healthy North African Control Subjects: Relationship with Diabetic Neuropathy. Hormone and Metabolic Research. 28(3). 128–132. 10 indexed citations

18.

Lassmann‐Vague, V., et al.. (1996). Insulin Kinetics in Type I Diabetic Patients Treated by Continuous Intraperitoneal Insulin Infusion: Influence of Anti-insulin Antibodies. Diabetic Medicine. 13(12). 1051–1055. 13 indexed citations

19.

Raccah, D., P. Disdier, L. Molle, et al.. (1995). La paralysie périodique thyréotoxique. Discussion du rôle de la Na-K-ATPase, à propos d'une observation. La Revue de Médecine Interne. 16(3). 209–211. 5 indexed citations

20.

Raccah, D., et al.. (1992). Poussée de rhumatisme inflammatoire après cure chirurgicale d'une maladie de Cushing: deux cas. La Revue de Médecine Interne. 13(4). 302–304. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact